Zexian Zeng

Zexian Zeng

Harvard University

H-index: 19

North America-United States

About Zexian Zeng

Zexian Zeng, With an exceptional h-index of 19 and a recent h-index of 18 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Immuno-oncology, Bioinformatics, Machine Learning.

His recent articles reflect a diverse array of research interests and contributions to the field:

A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer

ABHD6 suppresses colorectal cancer progression via AKT signaling pathway

Tutorial: integrative computational analysis of bulk RNA-sequencing data to characterize tumor immunity using RIMA

Transfer learning enables predictions in network biology

MetaTiME integrates single-cell gene expression to characterize the meta-components of the tumor immune microenvironment

Discovery of targets for immune–metabolic antitumor drugs identifies estrogen-related receptor alpha

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer

Sialylated IgG in epithelial cancers inhibits antitumor function of T cells via Siglec‐7

Zexian Zeng Information

University

Position

Postdoc Dana Farber Cancer Institute;

Citations(all)

4046

Citations(since 2020)

3989

Cited By

424

hIndex(all)

19

hIndex(since 2020)

18

i10Index(all)

25

i10Index(since 2020)

24

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Zexian Zeng Skills & Research Interests

Immuno-oncology

Bioinformatics

Machine Learning

Top articles of Zexian Zeng

Title

Journal

Author(s)

Publication Date

A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer

Journal of Translational Medicine

Mike Mason

Óscar Lapuente-Santana

Anni S Halkola

Wenyu Wang

Raghvendra Mall

...

2024/2/21

ABHD6 suppresses colorectal cancer progression via AKT signaling pathway

Molecular Carcinogenesis

Xiaoyu Xiong

Changjiang Yang

Yiteng Jin

Rui Zhang

Shuo Wang

...

2024/1/10

Tutorial: integrative computational analysis of bulk RNA-sequencing data to characterize tumor immunity using RIMA

Lin Yang

Jin Wang

Jennifer Altreuter

Aashna Jhaveri

Cheryl J Wong

...

2023/8

Transfer learning enables predictions in network biology

Nature

Christina V Theodoris

Ling Xiao

Anant Chopra

Mark D Chaffin

Zeina R Al Sayed

...

2023/6/15

MetaTiME integrates single-cell gene expression to characterize the meta-components of the tumor immune microenvironment

Nature communications

Yi Zhang

Guanjue Xiang

Alva Yijia Jiang

Allen Lynch

Zexian Zeng

...

2023/5/6

Discovery of targets for immune–metabolic antitumor drugs identifies estrogen-related receptor alpha

Cancer discovery

Avinash Sahu

Xiaoman Wang

Phillip Munson

Jan PG Klomp

Xiaoqing Wang

...

2023/3/1

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer

Science immunology

Giacomo Oliveira

Ann Marie Egloff

Alexander B Afeyan

Jacquelyn O Wolff

Zexiang Zeng

...

2023/9/8

Sialylated IgG in epithelial cancers inhibits antitumor function of T cells via Siglec‐7

Cancer Science

Tianrui Fan

Qinyuan Liao

Yang Zhao

Hui Dai

Shiyu Song

...

2023/2

Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-α

Cell Metabolism

Lijian Wu

Yiteng Jin

Xi Zhao

Kaiyang Tang

Yaoning Zhao

...

2023/9/5

Hippo Signaling Pathway Regulates Cancer Cell–Intrinsic MHC-II Expression

Cancer Immunology Research

Zexian Zeng

Shengqing Stan Gu

Nofal Ouardaoui

Carly Tymm

Lin Yang

...

2022/12/2

SOAR: a spatial transcriptomics analysis resource to model spatial variability and cell type interactions

bioRxiv

Yiming Li

Saya Dennis

Meghan R Hutch

Yawei Li

Mia S Broad

...

2022/4/17

Using an unsupervised clustering model to detect the early spread of SARS-CoV-2 worldwide

Genes

Yawei Li

Qingyun Liu

Zexian Zeng

Yuan Luo

2022/4/7

The 2022 generation

Nature Cancer

Mautin Barry-Hundeyin

Jian Carrot-Zhang

Talya Dayton

Shila Ghazanfar

Lillian M Guenther

...

2022/12

Statistical and machine learning methods for spatially resolved transcriptomics data analysis

Zexian Zeng

Yawei Li

Yiming Li

Yuan Luo

2022/3/25

Machine learning on syngeneic mouse tumor profiles to model clinical immunotherapy response

Science Advances

Zexian Zeng

Shengqing Stan Gu

Cheryl J Wong

Lin Yang

Nofal Ouardaoui

...

2022/10/14

TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response

Nucleic acids research

Zexian Zeng

Cheryl J Wong

Lin Yang

Nofal Ouardaoui

Dian Li

...

2022/1/7

Machine learning modeling of protein-intrinsic features predicts tractability of targeted protein degradation

Genomics, Proteomics & Bioinformatics

Wubing Zhang*

Shourya S Roy Burman*

Jiaye Chen

Katherine A Donovan

Yang Cao

...

2022/12/6

Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders

Journal for immunotherapy of cancer

Liye Zhou

Zexian Zeng

Ann Marie Egloff

Fan Zhang

Fei Guo

...

2022

Lipid exposure activates gene expression changes associated with estrogen receptor negative breast cancer

NPJ Breast Cancer

Shivangi Yadav

Ranya Virk

Carolina H Chung

Mariana Bustamante Eduardo

David VanDerway

...

2022/5/4

Deep learning for cancer type classification and driver gene identification

BMC bioinformatics

Zexian Zeng

Chengsheng Mao

Andy Vo

Xiaoyu Li

Janna Ore Nugent

...

2021/10

See List of Professors in Zexian Zeng University(Harvard University)

Co-Authors

H-index: 190
Gordon Freeman

Gordon Freeman

Harvard University

H-index: 124
Myles Brown

Myles Brown

Harvard University

H-index: 47
Yuan Luo

Yuan Luo

North Western University

H-index: 42
Jingshan Li

Jingshan Li

University of Wisconsin-Madison

H-index: 25
Richard Neapolitan

Richard Neapolitan

Northeastern Illinois University

academic-engine